PDF Federation of American Societies for Experimental

Federation of American Societies for Experimental Biology

2017 ANNUAL REPORT

FASEB 2017 Annual Report i

We advance health and well-being by promoting research and education in biological and biomedical sciences through collaborative advocacy and service to our societies and their members.

TABLE OF CONTENTS

01 President's Message

14 Resources for Scientists and the Public

02 FASEB Member Societies

03 Executive Director's Report

05 Introduction

17 Awards 18 Society Management

Services

20 2017 Financial Report

06 Science Policy & Advocacy

22 FASEB Board and Staff

10 Professional Development & Diversity

24 FASEB Committees

12 Science Research Conferences

28 FASEB Member Societies

ii The Federation of American Societies for Experimental Biology

BioArt 2017 cover and back cover photo credit: Marina Venero Galanternik, Daniel Castranova, Tuyet Nguyen, and Brant M. Weinstein

Looking back, 2017 was a challenging year for FASEB, for science, and for the nation.

Yet it also was a year of successes for FASEB and the biological and biomedical sciences. The bioscience community championed significant funding increases in the fiscal year (FY) 2017 budget for the National Institutes of Health (NIH), and it successfully turned back proposed cuts to the NIH FY 2018 budget. Harmful legislative proposals on tuition tax wavers and facilities and administrative charges were blocked.

Our Federation can claim some credit for these victories, thanks to advocacy by our outstanding public affairs team, our board members, and our member societies. In March 2017 our Capitol Hill Day was the largest ever, and our e-Action Alerts to Congress, which rallied scientists and researchers across the country, grew in number and impact.

PRESIDENT'S MESSAGE

I was honored to head the search committee, and with assistance from our board members and member society executive officers, we selected an outstanding new Executive Director, Frank Krause. Joining the FASEB team in July 2017, Frank hit the ground running. He guided our strategic planning process, the sale of the FASEB campus, organizational restructuring, and enhancing our connections with member societies. His dynamic leadership will ensure that FASEB's future is as bright as its past.

Strengthening relations between FASEB and our member societies has been a priority for me as president. I had very productive meetings with nine society councils at the Experimental Biology meeting in April, which provided valuable and actionable insights from member society executives for our national leaders in Washington. We also welcomed the Society of Toxicology as a new member.

In 2017 I joined with leaders from other research organizations to enthusiastically advocate for NIH funding and policies: two days of meetings with the NIH Principal Deputy Director and 14 Institute Directors in May, and in September, meetings on Capitol Hill to advocate for NIH funding increases as part of the annual Rally for Medical Research.

I have also encouraged our colleagues to dedicate even more energy and effort to support the National Science Foundation and other federal agencies that are instrumental in American science.

FASEB has experienced a renaissance of support and commitment to our Federation and its activities. FASEB Board and committee members have increased their involvement in FASEB activities and are working hard to develop policies and positions that will enable U.S. science to thrive.

Our collective energy and advocacy are more important today than at any time in our history. With the talent and resources of our membership, I am confident we will prevail.

Sincerely,

Thomas O. Baldwin, PhD President, 2017 FASEB Board of Directors

FASEB 2017 Annual Report 1

FASEB MEMBER SOCIETIES

BioArt 2017 photo credit: Dimitra Pouli, Sevasti Karaliota, Katia P. Karalis, and Irene Georgakoudi

APS

American Physiological Society

ASBMB

American Society for Biochemistry and Molecular Biology

ASPET

American Society for Pharmacology and Experimental Therapeutics

ASIP

American Society for Investigative Pathology

ASN

American Society for Nutrition

AAI

The American Association of Immunologists

AAA

American Association of Anatomists

TPS

The Protein Society

SDB

Society for Developmental Biology

APEPS

American Peptide Society

ABRF

Association of Biomolecular Resource Facilities

ASBMR

American Society for Bone and Mineral Research

ASCI

The American Society for Clinical Investigation

SSR

Society for the Study of Reproduction

TS

The Teratology Society

ES

Endocrine Society

ASHG

The American Society of Human Genetics

ISCB

International Society for Computational Biology

ACSM

American College of Sports Medicine

BMES

Biomedical Engineering Society

GSA

Genetics Society of America

AFMR

American Federation for Medical Research

HCS

The Histochemical Society

SPR

Society for Pediatric Research

SfG

Society for Glycobiology

AMP

Association for Molecular Pathology

SfRBM

Society for Redox Biology and Medicine

SEBM

Society for Experimental Biology and Medicine

AGE

American Aging Association

US HUPO

US Human Proteome Organization

SOT

Society of Toxicology

2 The Federation of American Societies for Experimental Biology

EXECUTIVE DIRECTOR'S REPORT

Friends and colleagues:

I was honored to be named Executive Director and Chief Executive Officer of FASEB in June 2017.

Most of my career has been devoted to supporting scientists and physicians via their professional organizations. I came to FASEB from the American Geophysical Union, where I served as Chief Operating Officer. I also held senior positions in publishing and business development at the American Medical Association in Chicago.

FASEB has a rich history in the biological sciences. Our roster of 31 member societies work across a broad range of scientific disciplines, doing truly important work that benefits human health. That made my decision to join FASEB an easy one.

Yet even with a stellar track record, change is afoot at FASEB. One of my first tasks was to begin managing the sale of the campus. Leasing office space to member societies at one time provided significant revenue for programs and initiatives. In 2016, the FASEB Board decided that continuing to operate the campus was not viable long term, and the campus was put up for sale in 2017. Rochambeau, The French International School, has a contract to purchase the campus, and FASEB is restructuring its business model for the post-sale era.

FASEB is also undergoing a cultural shift, reinvigorating its focus on service to our members and the community, and stepping up collaboration with members and other partners in the biomedical research community. A new strategic plan was developed and approved by the Board in December 2017. The plan is anchored by five goals--Public Affairs and Science Policy, Research and Education, Public Engagement, Talent Pool, and Organizational Excellence--and collaboration is the common thread binding them all.

In addition to its well-known strengths in public affairs, FASEB is more actively promoting other programs and services that provide value to the scientific community: The FASEB Journal, Science Research Conferences, and diversity and inclusion programming.

What hasn't changed is FASEB's reputation among key constituencies. Known as the policy voice for the biological sciences, FASEB continues to be a Washington leader in legislative affairs and science policy, and is known as an honest broker for its member societies and the scientists they represent.

Our mission of service to our member societies, our clients, and the biological and biomedical sciences continues to be our core purpose, and I am thrilled to serve.

Frank Krause, MBA, CAE FASEB Executive Director

FASEB 2017 Annual Report 3

FASEB IN 2017: CREATING A CULTURE OF COLLABORATION

"FASEB's priority in 2017 was reinforcing

our robust network of member societies, government stakeholders, and private sector institutions, and elevating the groundbreaking work of biological and biomedical scientists and researchers."

BioArt 2017 photo credit: Kevin A. Murach, Charlotte A. Peterson, and John J. McCarthy 44 TThhee FFeeddeerraattiioonn ooff AAmmeerriiccaann SSoocciieettiieess ffoorr EExxppeerriimmeennttaall BBiioollooggyy

FASEB knows the catalyzing effect of collaboration. The collective action of our member societies and their members unlocks the vast potential of the biosciences and creates a fertile environment for pioneering discovery and invention.

This culture of collaboration not only advanced policies for biological and biomedical researchers in 2017, it allowed FASEB to share information and leverage relationships on behalf of our member societies and their members.

Cooperative relationships and strategic alliances will continue to be a key enabler of efficiency, scale, and value in FASEB. Collaborative business processes and technologies spark innovation and reduce costs, and formal partnering opportunities such as meetings and conferences augment our capabilities.

Alliances were key to FASEB's growth, operational efficiency, member engagement, and other strategic goals in 2017 and will continue in the future.

Certainly, FASEB faced powerful forces of change in 2017--external competitive pressures and challenges within our own organization. Through partnership and innovative leadership, FASEB addressed those challenges and embarked on a path toward sustainability.

That path forward was buttressed by FASEB's adherence to a strong financial foundation, a deep commitment to policies that advance biomedical and biological research, and a profound belief in the power of cooperative advocacy.

In addition, innovative technologies and services helped foster greater participation through social media, webinars, and the Internet to break down geographic boundaries. These opportunities will expand to meet the evolution of technology and the needs of our members.

A wide range of partners have always had a stake in FASEB's future, and, more importantly, in the future of our member societies. For that reason, FASEB's priority in 2017 was reinforcing our robust network of member societies, government stakeholders, and private sector institutions, and elevating the groundbreaking work of biological and biomedical scientists and researchers.

FASEB 2017 Annual Report 5

SCIENCE POLICY & ADVOCACY

Participants at the "Responsible Communication of Basic Biomedical Research: Enhancing Awareness and Avoiding Hype" workshop in June 2017, l. to r.: FASEB President Thomas O. Baldwin, PhD; NIGMS Deputy Director Judith H. Greenberg, PhD; FASEB 2016 President Hudson Freeze, PhD; and NIGMS Director Jon R. Lorsch, PhD.

Throughout a turbulent 2017, FASEB worked with its member societies, member society staff, government officials, and advocacy partners to advance research funding and policies that stimulated the biological and biomedical sciences. FASEB offered trusted testimony and petitioned lawmakers to advance policies on behalf of working scientists.

The FASEB Office of Public Affairs (OPA) conducted in-depth policy analyses, developed and executed legislative strategies, and provided communication and technical support for all FASEB public policy initiatives. FASEB's reputation as the voice of the biomedical research community is such that legislators, federal agencies, and other organizations seek the perspectives of FASEB's leadership and public affairs team when science-related issues arise.

6 The Federation of American Societies for Experimental Biology

Regina Nuzzo, PhD, (r.), Gaulladet University professor and freelance journalist, on the "How does science communication affect the biomedical research landscape?" panel at the "Responsible Communication" workshop.

At the 2017 Capitol Hill Day, Hudson Freeze, PhD, provides an update on rare disease research funded by NIH.

Advocating for Sustained Federal Support for Fundamental Research

Federal funding for biological and medical research was a core issue for FASEB and the more than 130,000 scientists represented by its 31 member societies in 2017. Buoyed by continued bipartisan congressional support that, ultimately, led to two consecutive $2 billion increases in funding for the National Institutes of Health (NIH), the FASEB leadership and OPA staff worked diligently to maintain this momentum and support in a challenging political environment.

In March 2017, FASEB hosted a recordsetting 55 scientists from 28 states for its annual Capitol Hill Day. In addition to meetings with over 110 congressional offices, the day featured a congressional briefing highlighting the importance of basic research funding in unraveling the mysteries of rare diseases. Following their advocacy successes in Washington,

participants were encouraged to continue to engage with congressional representatives in their home districts.

Although fiscal year (FY) 2017 appropriations were still undecided at the time of Capitol Hill Day, FASEB advocated for completion of the FY 2017 omnibus appropriations bill and looked ahead to FY 2018. In its Federal Funding for Biomedical and Related Life Sciences Research FY 2018 publication, FASEB recommended increased funding levels for the five federal agencies of interest to FASEB members: NIH, National Science Foundation (NSF), U.S. Department of Agriculture research programs, U.S. Department of Energy Office of Science, and U.S. Department of Veterans Affairs (VA) Medical and Prosthetic Research Program. These recommendations served as the basis of FASEB's testimony on the FY 2018 appropriations to the U.S. House and U.S. Senate committees that oversee these agencies.

Six years after enactment, the Budget Control Act of 2011 continued to wreak havoc on the federal appropriations

process. Lawmakers frequently invoked the Act's preestablished discretionary spending caps for not backing budget increases to agencies supported by discretionary funds, such as NIH and NSF. Thus, FASEB joined forces with Research!America and other advocacy organizations in a campaign to "Raise the Caps" and promote timely completion of the FY 2018 appropriations.

FASEB's e-Action alerts continued to be effective for engaging scientists on important issues. Early versions of the Tax Cut and Jobs Act of 2017 included a provision that would have altered the U.S. tax code, making graduate student tuition waivers taxable income. In addition to highlighting the financial hardships on graduate students in science, technology, engineering, and math programs in letters to congressional leadership and conference committee members, an e-Action alert generated 22,451 messages from 7,150 individuals to all 100 Senate offices and 414 House offices in three days. The proposal was excluded from the final legislation, a major victory for the research community.

FASEB 2017 Annual Report 7

EFFECTIVE OCTOBER 24, 2017

Reforming Animal Research Regulations: Workshop RReepcorotAomAfMamnC,Aeapnnriddl 1aC7tO,i2Go0Rn1,7swwittohorakRsssheiospdtauonrccgeaefnroiRzmeedNgbAyuBFlRaAtSoErBy, Burden

Rep. John Lewis (D-GA, second from l.) meets with members of the Georgia delegation during Capitol Hill Day.

Rep. Gregg Harper (R-GA) with American Physiological Society representative Jane Reckelhoff, PhD, during Capitol Hill Day.

Promoting Regulatory Efficiency, Animal Welfare, and Sound Science

In April 2017, FASEB convened a workshop with the Association of American Medical Colleges, the Council on Governmental Relations, and the National Association for Biomedical Research to develop strategies for streamlining federal regulations, policies, and guidelines governing the use of animals in research. Consensus recommendations were developed for federal agencies involved in the oversight of federally funded animal research, addressing the numerous conflicting, outdated, or ineffective regulations that have failed to improve animal welfare.

FASEB continues to be a leading advocate for investigator access to appropriate animal models for research. In November 2017, FASEB addressed the leadership of the U.S. Senate Committee on Appropriations and the Senate Appropriations Subcommittee on Military Construction, Veterans Affairs, and Related Agencies, asking that they reject an amendment that would prohibit the VA

from conducting research using canine models. The amendment, submitted by U.S. Rep. Dave Brat (R-VA), was attached to H.R. 3219, the Make America Secure Appropriations Act, 2018, which passed unanimously in the House with the amendment intact. In its letter, FASEB highlighted the many health advances resulting from VA research using dogs and cautioned that prohibiting their use may create obstacles to improving veterans' health.

FASEB also submitted comments to NIH regarding anticipated future needs for nonhuman primate resources. These comments highlighted potential increases in the use of common marmosets in biomedical research due to their physiological and anatomical similarities with humans. New technologies such as CRISPR/Cas gene editing may allow for the development of transgenic nonhuman primate models that more closely mimic human disease, requiring additional resources to meet the research demands.

Enhancing Research Transparency

In February 2017, FASEB leadership and staff participated in a roundtable

discussion hosted by the National Institute of Neurological Disorders and Stroke (NINDS) to develop strategies to help make research presented at scientific conferences more transparent and rigorous. One idea that resulted from discussions was the use of icons to indicate certain aspects of experimental design and data presentation. The use of icons was piloted at several FASEB Science Research Conferences in 2017, an effort highlighted in an August Nature commentary coauthored by NINDS and FASEB representatives.

In June 2017, FASEB joined forces with the National Institute of General Medical Sciences (NIGMS) to host "Responsible Communication of Basic Biomedical Research: Enhancing Awareness and Avoiding Hype," a workshop to explore the role of science communication in building public trust in the scientific enterprise. The workshop brought together a diverse group of experts who disseminate and publicize basic biomedical research: scientists, including those who study communications; academic and corporate communications officers; policy advisors; and journalists. Participants discussed the problems of hyped research and the difficulties of communicating in today's

8 The Federation of American Societies for Experimental Biology

Office of Public Affairs publications provide insight and guidance to FASEB member societies and their members

media landscape, motivations for certain forms of science communications, the inherent features of science that make communicating about it challenging, and the role of press releases in promoting research progress.

Highlighting the Importance of Shared Research Resources

Shared research resources--from core facilities to living collections and national laboratories--make efficient use of funds and broaden researchers' access to advanced technologies and materials. In January 2017, FASEB launched a survey to collect information about researchers' experiences with shared research resources. The feedback from 751 respondents informed recommendations to improve the funding and business operations of shared resource facilities, increase discoverability and access, better meet evolving research needs, and professionalize careers in shared resource development and management. The project garnered positive feedback, both for filling key information gaps and providing thoughtful, action-oriented recommendations.

Office of Public Affairs 2017 Publications

SCIENCE POLICY STATEMENTS AND REPORTS ? Reforming Animal Research Regulations: Working

Recommendations to Reduce Regulatory Burden ? Maximizing Shared Research Resources, Part I:

Recommendations from the Federation of American Societies for Experimental Biology ? Federal Funding for Biomedical and Related Life Sciences Research FY 2018 ? Washington Update

BREAKTHROUGHS IN BIOSCIENCE AND HORIZONS IN BIOSCIENCE ? Secrets of the Human Brain Revealed:

Development, Disease & the Zika Virus ? Liquid Biopsies: A New Way to Diagnose,

Understand & Track Cancer

DATA COMPILATIONS AND FACT SHEETS ? FASEB Advocacy Tool Kit ? FASEB Federal Science Budget Information ? Federal Funding by State and District ? Education and Employment of Biological and Medical

Scientists 2016: Data from National Surveys ? The National Science Foundation:

Fundamental Research Leads to Discovery ? NIH Research Funding Trends: FY 1995--2016 ? Federal Funding for Biomedical and

Related Life Sciences Research FY 2017 ? Facts on Studies with Dogs

FASEB 2017 Annual Report 9

PROFESSIONAL DEVELOPMENT & DIVERSITY

Maximizing Access to Research Careers (MARC)

For more than 30 years, FASEB has promoted diversity in the biomedical and behavioral sciences, as well as the training and advancement of underrepresented students, postdoctoral fellows, early-career scientists, and faculty through grants funded by the Maximizing Access to Research Careers (MARC) Program. Through MARC funding, the FASEB Office of Sponsored Programs, Diversity and Grants Administration is able to offer a variety of programs and activities, including:

? support for FASEB member societies' diversity program initiatives;

? travel awards for faculty and students, and for poster/oral presenters (students and postdoctoral fellows), to attend member societies' scientific meetings and conferences;

? travel awards for underrepresented scientists, senior postdoctoral fellows, and graduate students to attend FASEB Science Research Conferences;

? s ponsorship of grantsmanship training seminars and workshops at scientific meetings during summer sessions and at predominantly minority institutions year-round;

? sponsorship of career development programs and activities for underrepresented researchers and students at Experimental Biology and select FASEB member societies' meetings and conferences;

? support for the MARC Program Advisory Board Annual Meeting; and

? hosting the MARC Program activities and InfoNet on the FASEB website.

The MARC Program was created by the National Institute of General Medical Sciences (NIGMS) to increase the number of highly trained underrepresented biomedical and behavioral scientists in leadership positions to significantly impact U.S. health-related research needs.

In December 2017, FASEB closed out one of two NIGMS/NIH T36 MARC Ancillary Training Program projects. The grant was awarded to FASEB in April 1981 as the Visiting Professors for Minority Institutions

2017 MARC Program Activity

2017 FASEB MEMBER SOCIETY PARTNER TRAVEL AWARDS

APS AAI SDB ACSM HCS ABRF

2 SEACSM 2

17 TS

1

2 SSR

1

7 ASHG

13

4 SFG

1

4 EB2017 42

NON-FASEB MEMBER SOCIETY MEETINGS

2017 Annual Biomedical Research

Conference for Minority Students

(ABRCMS)

56

FASEB Postdoc Preparation

Institute 2017

44

TOTAL AWARDS

196

10 The Federation of American Societies for Experimental Biology

Program. The activities supported by this grant in 1981 and 1982 were key in establishing the MARC Program, which has grown substantially over the past three decades to include a variety of diversity resources program services and activities.

2017 FASEB Member Society PartnerSponsored Exhibit Booths at ABRCMS

? American Physiological Society (APS)

? American Society for Pharmacology and Experimental Therapeutics (ASPET)

? American Society for Investigative Pathology (ASIP)

? American Association of Anatomists (AAA)

? The Protein Society (TPS)

? Society for Developmental Biology (SDB)

? Association of Biomolecular Resource Facilities (ABRF)

? The Teratology Society (TS)

? Endocrine Society (ES)

? The American Society of Human Genetics (ASHG)

? Biomedical Engineering Society (BMES)

? Society for Experimental Biology and Medicine (SEBM)

? American Aging Association (AGE)

2017 FASEB MARC Strategic Partnerships Activity

FASEB's strategic partners are critical to the success of our MARC programs and provide those we serve opportunities to be mentored and to network with peers and other professionals in their fields.

MARC Program 2017 activities: ? Hosted the NIH-funded National

Research Mentoring Network Partners in Action Meeting (Bethesda, April)

? Organized and managed the NIGMSfunded 2017 Training, Workforce Development & Diversity Program Directors' Meeting (Baltimore, June)

? Organized and managed the Presentation Practice and Mentoring Workshop for Undergraduate Students at the 2017 Annual Biomedical Research Conference for Minority Students (Phoenix, November)

Career Centers

Professional scientific organizations provide vast resources for individuals pursuing a career in science, including scientific meetings and conferences, journals and publications, and career services. FASEB is committed to helping improve quality of life for life science researchers through the services and benefits offered to member society members and the science community at large.

Meeting-related Career Services

FASEB offers career services at professional meetings, hosted by member societies and others, to provide job applicants and employers informal environments to meet, conduct interviews, and explore employment opportunities. In addition, ancillary career services--career development seminars, workshops, and cover letter and resume critiques--are provided for Career Center registrants and attendees of the various meetings.

Year-round Career Services

FASEB offers year-round career services through the Life Science Job Center, allowing job seekers and employers to register and manage their accounts, create profiles and post resumes, view applications and available employment opportunities, create personalized job alerts, and learn about upcoming career centers.

EB2017 Career Center Activity

EMPLOYMENT OPPORTUNITIES AND LISTINGS

(posted online and on poster boards)

59 unique employers and organizations

132 jobs and positions posted

46 postings listed multiple positions

JOBSEEKERS

(onsite registrants during EB2017)

61 job seekers

RESUME CRITIQUES AND CAREER COUNSELING (ONE-ON-ONE) SESSIONS

205 participants

CAREER CENTER PRESENTATIONS AND SESSIONS

41 sessions (including four sessions with NIH staff members)

13 speakers (including two NIH staff members)

4 peer or faculty mentors (onsite mentoring; presentation practice)

FASEB also provided onsite management support for the Career Centers at The Association of Biomolecular Resource Facilities (ABRF) and The American Society of Human Genetics (ASHG) 2017 annual meetings.

FASEB 2017 Annual Report 11

SCIENCE RESEARCH CONFERENCES

Attendees at the TGF- Superfamily: Signaling in Development and Disease Science Research Conference in Lisbon, Portugal, July 2017.

FASEB Science Research Conferences (SRCs) promote dialogue among investigators in the biological and biomedical sciences to spur innovation and the exchange of knowledge. Conferences offer attendees opportunities to learn and network through general sessions, poster sessions, shared meals, meet-the-expert sessions, and career development workshops.

In creating conferences, the FASEB SRC Advisory Committee reviews and selects conference proposals submitted by members of FASEB societies and others. Selected areas of research addressed by the SRC series include epigenetics, biochemistry, genetics, genomics, immunology, nutrition, molecular biology, oncology, and many others.

In 2017, the SRCs welcomed prominent scientists, faculty, postdoctoral fellows, and graduate students working in areas experiencing rapid scientific advances. Thirty conferences were held in Arizona, Colorado, Florida, Louisiana, Montana, and Vermont--and in the United

Kingdom and Portugal--enhancing the opportunities for new and senior scientists to discuss their research and network with colleagues.

Through these conferences, the SRC series importantly supports FASEB member societies and the FASEB Office of Public Affairs (OPA) by cultivating interest from non-member attendees who would like information on society membership, or on policy issues important to the biological and biomedical research fields.

SRC Series 2017 Attendance

3,504 total 117 per conference (avg.)

28 percent from outside the U.S.

New in 2017, FASEB leveraged the SRCs to test whether key information can be conveyed effectively employing icons--images used to communicate the incorporation of specific experimental methods--in presentations and posters. Participation in this initiative was voluntary. Shai D. Silberberg, PhD, of the National Institute of Neurological Disorders and Stroke and FASEB colleagues described this pilot effort in a commentary published in Nature

(10 August 2017). This initiative continues through 2018.

FASEB encourages and promotes applications from new and veteran organizers. By exploring new venues, both domestically and internationally, FASEB hopes to give organizers and participants additional options for hosting conferences.

12 The Federation of American Societies for Experimental Biology

WE ARE GRATEFUL FOR THE GENEROUS SUPPORT OF OUR 2017 SRC SPONSORS

PLATINUM-LEVEL

SPONSORS

($10,000+)

a2 Milk Company Abbvie Alex's Lemonade Stand Foundation American Gastroenterological Association Amgen Inc. Anonymous Donors Arla Foods AstraZeneca Avanti Polar Lipids Biolegend Burroughs Wellcome Fund Celgene Center for Biological Systems Engineering Chromadex Company of Biologists Crohn's & Colitis Foundation Dana-Farber/Boston Children's Danone Nutrica Research Digestive Diseases Week DSM Nutritional Products Edward P. Evans Foundation FrieslandCampina Domo Gabrielle Angel Foundation Genentech, Inc. Gilead Glenn Medical Research Foundation Illumina Incyte Ipsen Ironwood Pharmaceuticals Jeffery Bacha Kadmon Corporation Kenneth Rainin Foundation Lowell/ Pernis Family March of Dimes Marriott Foundation Mead Johnson Nutrition Merck NIH NSF Otsuka America Pharmaceutical Paul J. Davis, MD Pfizer Picower MIT PKD Foundation Regeneron St. Jude The Bright Foundation The Pershing Square Foundation USDA

GOLD-LEVEL SPONSORS ($5,000--$9,999)

Acceleron Antibodies Incorporated Biogen Idec Biostime Institute of Nutrition and Care Bio-Techne Blade Therapeutics, Inc. Cayman Chemical Company, Inc. Cydan Development, Inc. Cystic Fibrosis Foundation Duke-NUS Medical School Dupont EMD Serono Ferring Genetic Information Research Institute GlaxoSmithKline GTx Intelligent Imaging Innovations, Inc. Janssen Kevin Turner Leukemia & Lymphoma Society Ludwig Institute for Cancer Research Ltd Millennium (Takeda Oncology) Nestle Nestle SA Novartis Institutes for BioMedical Research Novo Nordisk NYU Langone Medical Center Palladio Biosciences, Inc. Pliant Therapeutics PLOS Plum Foundation Proctor and Gamble Rebiotix, Inc. Regulus Therapeutics Rodin Therapeutics Sandoz Sanofi Scholar Rock, Inc. TESARO TR&D University of California, Davis Versartis Vertex Pharmaceuticals Y. Zhao

SILVER-LEVEL SPONSORS ($2,000--$4,999)

Abbott Nutrition Actelion Pharmaceuticals, Ltd. Anonymous ApoPharma Bachem AG Badrilla

Bright Focus Foundation Bristol Myers-Squibb Calico Life Sciences LLC CSSI DaVita Kidney Care Elsevier Expression Systems FEI/Thermofisher Fresenius Medical Care North America Fundaci?n Ram?n Areces German Society for Developmental Biology Growth Hormone Research Society Harold Hamm Diabetes Center Hilmar Ingredients Immune Design Ingredion Incorporated J. Keith Joung (Joung Lab) The JM Foundation/University of Miami Journal of Cell Biology Journal of Lipid Research Journal of Physiology Kerry Health & Nutrition Institute Lilly Lovelace Biomedical MCW Cancer Center Mironid Mitobridge Nature Ono Pharmaceuticals Prolacta Research and Diagnostic Systems RGB Ribon Therapeutics, Inc. Rigaku RTLGenomics Science Signaling Second Science, Inc. Shenzhen ChipScreen Bioscience, Inc. Sociedad Espa?ola de Bioqu?mica y Biolog?a Molecular (SEBBM) Sophion Bioscience, Inc. Taylor and Francis Group Temple University Thermo Scientific Biomarker Thomas Jefferson University (Sidney Kimmel Medical College) Tishcon Corp Universidad Aut?noma de Madrid University of Colorado Anschutz Medical Campus University of Strathclyde - SIPBS Waters Corporation Wiley (British Journal of Pharmacology) Yale Cancer Center

BRONZE-LEVEL

SPONSORS

($50--$1,999)

American Society for Microbiology AAAS Science Signaling ACS Chemical Biology Agilent American Journal of Physiology: Gastrointestinal and Liver Amicus Therapeutics, Inc. Amydis ASBMB/JBC ASPET ATCP Biochemical Journal Biolog Biomolecules (MDPI AG) Cell Press Cell Signaling Technology Center for RNA Molecular Biology (CRMB) Cisbio Echelon, Inc. Edison Pharmaceuticals, Inc. EMBO Enzo Life Sciences Foundation for the NIH Genomic Vision Gerald Siu Consulting, LLC Hello Bio Icagen JBC Jennewein Jeremy Thorner John Blenis Journal of Cell Science Journal of General Physiology Journal of Medicinal Chemistry Kerafast Khondrion Mebias Discovery, LLC Metabolic Solutions Development Company Metagenics MilliporeSigma Natalie Ahn Nature Immunology New England Biolabs, Inc. Nikon Instruments Ocu-Science Plant Physiology PTM Biolabs Inc. Research Diets, Inc. Seres Therapeutics The Plant Cell Trevana, Inc. Worldwide Cancer Research

FASEB 2017 Annual Report 13

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download